Bio-Techne Corporation
Find Ratings Reports
-0.06 |
-0.01%
BIO-TECHNE CORP's gross profit margin for the second quarter of its fiscal year 2021 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. BIO-TECHNE CORP is extremely liquid. Currently, the Quick Ratio is 3.50 which clearly shows the ability to cover any short-term cash needs. TECH managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.
During the same period, stockholders' equity ("net worth") has increased by 15.00% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
| Income Statement | Q2 FY21 | Q2 FY20 |
|---|---|---|
| Net Sales ($mil) | 224.25 | 184.93 |
| EBITDA ($mil) | 76.54 | 56.76 |
| EBIT ($mil) | 55.65 | 36.2 |
| Net Income ($mil) | 46.27 | 119.62 |
| Balance Sheet | Q2 FY21 | Q2 FY20 |
|---|---|---|
| Cash & Equiv. ($mil) | 282.95 | 243.95 |
| Total Assets ($mil) | 2067.87 | 1998.42 |
| Total Debt ($mil) | 305.12 | 464.04 |
| Equity ($mil) | 1521.92 | 1323.35 |
| Profitability | Q2 FY21 | Q2 FY20 |
|---|---|---|
| Gross Profit Margin | 76.6 | 76.76 |
| EBITDA Margin | 34.12 | 30.68 |
| Operating Margin | 24.82 | 19.58 |
| Sales Turnover | 0.39 | 0.37 |
| Return on Assets | 8.46 | 9.76 |
| Return on Equity | 11.5 | 14.75 |
| Debt | Q2 FY21 | Q2 FY20 |
|---|---|---|
| Current Ratio | 4.61 | 4.43 |
| Debt/Capital | 0.17 | 0.26 |
| Interest Expense | 3.59 | 4.87 |
| Interest Coverage | 15.52 | 7.43 |
| Share Data | Q2 FY21 | Q2 FY20 |
|---|---|---|
| Shares outstanding (mil) | 38.77 | 38.28 |
| Div / share | 0.32 | 0.32 |
| EPS | 1.15 | 3.02 |
| Book value / share | 39.26 | 34.57 |
| Institutional Own % | n/a | n/a |
| Avg Daily Volume | 201753.0 | 160461.0 |
BUY. BIO-TECHNE CORP's P/E ratio indicates a significant premium compared to an average of 53.90 for the Chemical Manufacturing subsector and a significant premium compared to the S&P 500 average of 43.53. To use another comparison, its price-to-book ratio of 10.32 indicates a significant premium versus the S&P 500 average of 4.31 and a significant discount versus the subsector average of 14.36. The price-to-sales ratio is well above both the S&P 500 average and the subsector average, indicating a premium. The valuation analysis reveals that, BIO-TECHNE CORP seems to be trading at a premium to investment alternatives.
| Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TECH 92.50 | Peers 80.41 | TECH 62.87 | Peers 76.40 | |||||||||||||||||||||
|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations. TECH is trading at a premium to its peers. |
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. TECH is trading at a discount to its peers. |
|||||||||||||||||||||||
| Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
| TECH 58.55 | Peers 37.66 | TECH 24.47 | Peers 2.08 | |||||||||||||||||||||
|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations. TECH is trading at a significant premium to its peers. |
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. TECH trades at a significant premium to its peers. |
|||||||||||||||||||||||
| Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
| TECH 10.32 | Peers 14.36 | TECH -11.70 | Peers 3.56 | |||||||||||||||||||||
|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. TECH is trading at a significant discount to its peers. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, TECH is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
| Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
| TECH 19.66 | Peers 12.17 | TECH 7.28 | Peers 16.27 | |||||||||||||||||||||
|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. TECH is trading at a significant premium to its subsector. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. TECH significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||
